Literature DB >> 1698341

Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast.

U Raju1, J D Crissman, R J Zarbo, C Gottlieb.   

Abstract

Epitheliosis is a benign intraluminal proliferation in the breast ducts and lobules that needs to be distinguished from ductal carcinoma in situ (DCIS). The histogenesis and differentiation of cells comprising epitheliosis have been the subject of some controversy. We evaluated the expression of a high-molecular-weight keratin (34 beta E12), muscle-specific actin (HHF-35), and S-100 protein immunoreactivity in formalin-fixed sections of the breast with epitheliosis and DCIS. In 28 of 30 cases of epitheliosis, there was strong HMW keratin immunoreactivity in the streaming sheetlike intraluminal proliferations. In contrast, 35 of 40 cases of DCIS (nonpapillary and papillary) were nonreactive for HMW keratin; the other five were weakly reactive. Furthermore, in 10 cases of DCIS, some ducts had isolated or small aggregates of HMW keratin-positive benign cells on the luminal aspects of the neoplastic proliferation that were reminiscent of a pagetoid pattern. Muscle actin-stained sections were analyzed to assess myoepithelial (ME) cell participation in epitheliosis. Muscle actin-positive ME cells were present at the periphery of the involved ducts but were absent or rare within epitheliosis. The distribution of ME cells--i.e., at the periphery of the spaces involved--was similar in DCIS and epitheliosis. S-100 protein was weakly but relatively consistently expressed by epitheliosis, but all cases of DCIS were negative. Six cases of atypical ductal hyperplasia included in the study were negative for HMW keratin, muscle actin, and S-100 protein. The immunohistochemical profile of epitheliosis indicates that it is primarily an epithelial proliferation with strong HMW keratin and weak S-100 protein expression but without ME cell participation. The distinct differences in HMW keratin expression of epitheliosis and intraductal carcinoma appear to reflect a consistent antigenic difference in these two biologically distinct forms of proliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698341     DOI: 10.1097/00000478-199010000-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  Epithelial Proliferative Lesions and Carcinomas in Fibroadenomas of the Breast.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

2.  An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions.

Authors:  W Böcker; B Bier; G Freytag; B Brömmelkamp; E D Jarasch; G Edel; B Dockhorn-Dworniczak; K W Schmid
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.

Authors:  G M K Tse; P-H Tan; T K F Ma; C B Gilks; C S P Poon; B K B Law
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 4.  Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature.

Authors:  T Miyamoto; Y Hagari; S Inoue; T Watanabe; T Yoshino
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

5.  Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34betaE12 antibody.

Authors:  Magali Lacroix-Triki; Eliane Mery; Jean-Jacques Voigt; Luc Istier; Philippe Rochaix
Journal:  Virchows Arch       Date:  2003-04-24       Impact factor: 4.064

6.  Spectrum of carcinoembryonic antigen immunoreactivity from isolated ductal hyperplasias to atypical hyperplasias associated with infiltrating ductal breast cancer.

Authors:  F C Schmitt; L Andrade
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

7.  [Immunohistochemistry in breast pathology: differential diagnosis of epithelial breast lesions].

Authors:  W Böcker; D Hungermann; S Weigel; J Tio; T Decker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

8.  An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ.

Authors:  W Böcker; B Bier; G Freytag; B Brömmelkamp; E D Jarasch; G Edel; B Dockhorn-Dworniczak; K W Schmid
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.

Authors:  R Bässler; B Katzer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.

Authors:  B Bier; A Douglas-Jones; M Tötsch; B Dockhorn-Dworniczak; W Böcker; B Jasani; K W Schmid
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.